Warm congratulations to Prof Susan Clark FAA FAHMS, who was one of 28 new Fellows elected yesterday during the 2020 Scientific Meeting of the AAHMS. Those elected were honoured for their outstanding contributions to the health and medical research landscape in Australia.
Recognised worldwide as a pioneer in the field of epigenetics, Sue’s research has revolutionised the field by contributing to vital advances in novel technologies for profiling DNA methylation changes in early development and cancer.
Sue is Leader of the Genomics and Epigenetics Research Theme at the Garvan Institute of Medical Research in Sydney, where she is also Head of the Epigenetics Research Lab. Her current research involves understanding the 3D epigenetic landscape of large-scale domains in cancer, and developing new genome-wide sequencing and bioinformatic protocols to map DNA methylation, histone modifications and regulatory RNA profiles. Her team has recently demonstrated that epigenetic changes in cancer encompass large genome-wide domains, resulting in global and coordinated gene silencing and activation, which provide new insights for disease diagnosis and treatments.
Read more on the Garvan website and AAHMS news.
Pioneering cancer epigenetics: Susan Clark elected Fellow of @AAHMS_health. @Suscla1 used genome‐wide sequencing to find that epigenetic changes in cancer can result in coordinated gene silencing and activation. @GarvanInstitute. See all #AAHMSfellows https://t.co/tShgsFbeDJ pic.twitter.com/15l7Y5ewLN — AAHMS (@AAHMS_health) October 14, 2020